MedPath

EFFECT OF ORAL PREGABALIN ON LARYNGOSCOPY RESPONSE WHEN GIVEN AS PREMEDICATIO

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/01/048997
Lead Sponsor
MAHARAJA AGRASEN MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA I AND II

Exclusion Criteria

1 ASA III and IV

2 Anticipated difficult airway ( Mallampati class III and IV, thyromental distance <6 cm , inter-incisor

distance <3 cm, and cervical instability)

3 Severe renal disease

4 Allergic to any anaesthetic medication

5 Obese (BMI greater than or equal to 30)

6 ischemic heart disease and major cardiac disorders

7 Patients on β- blockers or vasodilators

8 Patients who will require second attempt of intubation

9 Intubation exceeding 30 seconds

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the hemodynamic changes during laryngoscopy between patients taking pregabalin (group <br/ ><br>p) and patients taking placebo (group c).Timepoint: BASELINE(BEFORE MEDICATION), BEFORE INDUCTION , INDUCTION , AFTER LARYNGOSCOPY, 2 MIN , 4 MIN , 6 MIN , 8 MIN , 10 MIN .
Secondary Outcome Measures
NameTimeMethod
intraoperative hemodynamics , analgesic requirementTimepoint: perioperative periods
© Copyright 2025. All Rights Reserved by MedPath